Hyperinsulinemia, a hallmark of insulin resistance in T2D, results in sustained activation of insulin receptors—particularly the mitogenic insulin receptor isoform A—and increases circulating levels of insulin-like growth factor 1 (IGF-1) [7,8]. The gene discussed is IGF1; the disease is type 2 diabetes mellitus.